If you want to lift your grandkids, get up the stairs, haul groceries, and conquer all of life’s adventures with confidence as you age, here’s the science-backed secret: lift weights. Yep, those ...

Gaming with Kev lifts, trains, and scares his friends with Halloween-themed workouts in Weight Lifting Simulator 3. Study of 27.8M Americans may have revealed direct Alzheimer's cause 4 dead in ...

Feb 3 (Reuters) - Pfizer (PFE.N), opens new tab said on Tuesday its experimental obesity drug, which it acquired through the Metsera deal, showed up to 12.3% weight loss in patients without diabetes ...

Getting strong has never been more popular. How did we get here? By Danielle Friedman and Theodore Tae Our interest in pumping iron has exploded in recent years. Podcasters promote lifting as a key to ...

Eli Lilly said it will spend $3.5 billion to build a manufacturing plant in Pennsylvania's Lehigh Valley that will help make its next-generation obesity drugs. That includes a closely watched ...

Gov. Maura Healey plans to file a $63 billion fiscal 2027 budget Wednesday — a 3.8% increase that outpaces inflation and aims to rein in rising health care costs, while responding to federal funding ...

It can be a challenge to figure out where to start when you want to lose weight. But if you’ve recently started on a path to lose weight safely yet efficiently, doing cardio for weight loss is key.

New research highlights how consistent nutrition with Atkins can support success during weight wellness journeys DENVER, Jan. 15, 2026 /PRNewswire/ -- Atkins, the industry pioneer of the low-carb ...

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram and 4 mg doses at $149 per month for self-paying patients in an intensely ...

A pill version of the blockbuster weight-loss medication Wegovy is rolling out in the U.S., and people are already actively navigating prescriptions. Experts say that a pill version of the high-demand ...

An Eli Lilly drug candidate designed to hit three metabolic targets led patients to lose an average of 28.7% of their body weight in a late-stage clinical trial, setting a new high mark in the ...